| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $83,472,424 ) (Continued on the next page) |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34MH126008 | Optimizing residential treatment gains for adolescents through tailored behavioral parent training | 000 | 2 | NIH | 11/7/2023 | $248,063 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA277217 | Identification of enzymes inhibited by oncometabolites in Succinate Dehydrogenase mutant tumors | 000 | 2 | NIH | 12/13/2023 | $78,750 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32NS126298 | Maladaptive Remodeling of the Neuromuscular Synapse Following Central Nervous System Injury | 000 | 2 | NIH | 3/13/2024 | $74,292 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270372 | Chemotherapy-induced circadian master clock disruptions and fatigue | 003 | 2 | NIH | 4/16/2024 | $4,005 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270372 | Chemotherapy-induced circadian master clock disruptions and fatigue | 002 | 2 | NIH | 4/16/2024 | $26,706 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | 2401OHATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 12/12/2023 | $144,557 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K23HL168328 | Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis | 000 | 1 | NIH | 3/5/2024 | $190,620 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH134121 | Orchestrating tryptophan metabolites to protect neurodevelopment from prenatal stress | 000 | 1 | NIH | 3/7/2024 | $662,621 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K23HL168328 | Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis | 001 | 1 | NIH | 3/13/2024 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 002 | 1 | NIH | 4/25/2024 | $5,224 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 001 | 1 | NIH | 12/12/2023 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 000 | 1 | NIH | 12/12/2023 | $81,967 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34EY035783 | Identification of School-age Eye conditions Evaluation (ISEE) | 000 | 1 | NIH | 2/21/2024 | $267,006 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F30AI172189 | The Ikaros zinc finger transcription factor Eos as a candidate regulator of TH2 differentiation and effector function | 000 | 1 | NIH | 12/5/2023 | $42,794 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 001 | 1 | NIH | 2/9/2024 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 000 | 1 | NIH | 2/9/2024 | $42,794 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168045 | Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics | 000 | 1 | NIH | 12/20/2023 | $657,529 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA286017 | ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY | 000 | 1 | NIH | 1/1/2024 | $404,798 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA280007 | A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers | 000 | 1 | NIH | 12/29/2023 | $90,722 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03AI182416 | Generation of an ILC3-specific Cre driver in mice | 000 | 1 | NIH | 1/29/2024 | $70,875 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA279707 | Contributions of the Adipose Tissue to the Development of Pancreatic Cancer | 000 | 1 | NIH | 2/8/2024 | $506,842 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL164443 | SLC29A3 lysosomal transporter in hematopoietic homeostasis and disease | 000 | 1 | NIH | 2/8/2024 | $393,750 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AG078258 | E-PROOF: E-intervention for Protein Intake and Resistance Training to Optimize Function | 000 | 2 | NIH | 1/24/2024 | $177,188 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL166520 | Transcriptional Coordination and Gene Regulation by MED12 in the Cardiomyocyte | 000 | 2 | NIH | 4/19/2024 | $532,555 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168728 | Atrial and blood JNK in Postoperative AF | 000 | 8 | NIH | 3/1/2024 | $616,206 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K01AA030325 | Socio-cultural and community risk and resilience for alcohol related problems in youth | 002 | 3 | NIH | 4/22/2024 | $146,218 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DA058642 | Testing a multistage model of risk factors for cannabis use utilizing a measurement burst design among sexual minority women, sexual minority gender diverse individuals, and heterosexual women | 000 | 2 | NIH | 4/25/2024 | $699,139 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21MD018158 | The National Couples Health and Time Use Stress Biology Study (NCHAT-BIO): Biobehavioral Pathways to Population Health Disparities in Sexual Minorities | 000 | 2 | NIH | 12/26/2023 | $143,487 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI178624 | Tiny RNAs as new potential biomarkers for gammaherpesvirus-driven neurological and central nervous system diseases | 000 | 2 | NIH | 3/22/2024 | $192,590 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014199 | Machine learning drives translational research from drug interactions to pharmacogenetics | 000 | 2 | NIH | 2/16/2024 | $557,120 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH134402 | Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia | 000 | 2 | NIH | 4/24/2024 | $688,355 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R13HL174105 | Improving definitions and innovations for identification and prevention of postoperative opioid induced respiratory depression (OIRD) | 000 | 1 | NIH | 4/25/2024 | $9,963 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HS029001 | Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older Adults | 000 | 2 | AHRQ | 1/17/2024 | $395,192 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK137431 | Next generation of AAV vector targeting adipose tissue | 000 | 1 | NIH | 4/1/2024 | $487,463 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AG082044 | Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved | 000 | 1 | NIH | 4/22/2024 | $762,126 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS130308 | Mechanisms underlying regulation of injured axons in CNS autoimmunity | 000 | 1 | NIH | 12/15/2023 | $521,130 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH135117 | Progression of Social Cognitive Deficits in Mid- and Late-Life Schizophrenia Spectrum Disorders | 000 | 1 | NIH | 12/15/2023 | $835,605 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08DE033142 | Nanotransfection-based Cell Reprogramming to Drive Bone Revascularization in a Novel Mouse Model of Autogenous Cranioplasty | 000 | 1 | NIH | 4/2/2024 | $163,620 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21NR021060 | Modification of the B-SWELL Intervention to Improve Long Term Outcome Trends in Midlife Black Women | 000 | 1 | NIH | 3/15/2024 | $433,125 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA288444 | Modulation of ferroptotic cell death by mitochondrial calcium signaling | 000 | 1 | NIH | 3/15/2024 | $566,379 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21CA280452 | Exploring the interaction of lipid metabolism with the hexosamine pathway and tumor growth | 000 | 1 | NIH | 12/22/2023 | $220,894 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS131319 | Understanding the role of SCN8A in developmental and epileptic encephalopathy | 000 | 1 | NIH | 2/20/2024 | $374,350 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA286694 | Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia | 000 | 1 | NIH | 12/28/2023 | $78,750 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | T32HL166132 | Training Program in the Biology of Aging and Lung Diseases | 000 | 1 | NIH | 1/5/2024 | $169,899 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R13AG087673 | 5th Annual MAC (Midwest Aging Consortium) Aging Research Symposium | 000 | 1 | NIH | 4/8/2024 | $25,000 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014385 | Generative AI for retrosynthesis libraries | 000 | 1 | NIH | 1/9/2024 | $330,713 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA287261 | Fecal microbial transplantation for chemotherapy behavioral side effects | 000 | 1 | NIH | 1/18/2024 | $615,068 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R56AI181631 | Antagonize Host Survival and Immune Escape Mechanisms for Elimination of HIV Viral Reservoirs | 000 | 1 | NIH | 3/14/2024 | $758,970 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31CA288053 | Defining the biochemical properties and implications of NRAS mutant-specific BRAF interactions in melanoma | 000 | 1 | NIH | 3/14/2024 | $36,314 |
|